Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07425106

Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3)

Comparative Study of High Performance Low-Cost Optical Coherence Tomography

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
82 (estimated)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to complete performance testing of our custom optical coherence tomography (OCT) device to verify it can deliver retinal images of similar quality to a commercial OCT device. We will then add an angle-resolved low coherence interferometry (a/LCI module) to the device to make measurements of retinal tissue structure.

Detailed description

There is some evidence that certain changes in retinal structures could be an indicator of Alzheimer's disease (AD). We are developing a new technology that combines optical coherence tomography (OCT) and angle-resolved low coherence interferometry (a/LCI) to make light scattering measurements of retinal tissue structure. The first objective of this study is to compare performance characteristics of our custom OCT instrument to a commercial OCT instrument. Once we have optimized our device, the second objective will be to use the custom OCT-a/LCI device to identify retinal structure changes that could be possible AD biomarkers. For this study, the team will recruit volunteers to attend one study visit that is about 30 minutes long. For arm 1A (registered under NCT05530460), this visit will include examination with our custom OCT instrument, followed by examination with a commercial OCT system. For arms 1B and 2/3, the visit will include examination with the custom OCT-a/LCI instrument. This study will recruit participants with Alzheimer's disease and healthy controls.

Conditions

Interventions

TypeNameDescription
DEVICEretinal imaging with low-cost OCT-a/LCI deviceretinal imaging with low-cost OCT-a/LCI device

Timeline

Start date
2026-02-13
Primary completion
2027-02-01
Completion
2027-02-01
First posted
2026-02-20
Last updated
2026-02-25

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07425106. Inclusion in this directory is not an endorsement.